Navigation Links
KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model
Date:10/11/2007

so presented on KineMed's most advanced compound, KM-801, which is expected to enter clinical studies in 2008 for the treatment of Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's disease). KM-801 is a small-molecule agent, which has been shown to alter microtubule dynamics in nerve cells in preclinical studies (J Biol Chem. 2007 Jun 13). KineMed researchers have discovered that patients with ALS have more rapid rates of turnover of microtubules, which are integral to the structure and functionality of the motor neurons affected by the disease. By using an agent that can slow down this rate of turnover, KineMed has shown in preclinical studies that it can restore balance to this key metabolic pathway and improve both symptoms and survival. KineMed's KM-801 program is currently in IND-enabling studies to support the initiation of clinical trials next year.

KineMed KineMarker(TM) Product Programs in Neurobiology

KineMed's programs utilize proprietary in vivo technologies to indentify drug candidates that can modulate several key biological pathways involved in the pathogenesis and treatment of psychiatric and neurodegenerative disorders. This approach can be applied in clinical, as well as preclinical, settings.

KineMed's Neuroinflammation and Neurogenesis KineMarkers(TM) are more sensitive, reproducible and high-throughput than traditional methods, such as histological staining, and are safer than traditional radioisotope labeling methods. Areas of neurobiology where KineMed has active discovery programs include mood disorders, ALS, multiple sclerosis, Alzheimer's disease, Parkinson's disease, and diabetic neuropathy, as well as disorders of learning and memory.

About KineMed

KineMed, Inc. ("KineMed" or the "Company") is a drug discovery and development company employing its proprietary translational medicine technology (AquaTag(TM) and KineMarker(TM)) to both identify active drug candidates preclinically and confirm their therapeutic
'/>"/>

SOURCE KineMed Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. KineMed Presents Data Measuring Changes in Reverse Cholesterol Transport for the First Time
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
4. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
5. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
6. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
7. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
8. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
9. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
10. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
11. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... , July 10, 2014  BC Technical, the largest ... MiE America , Inc., a leading provider of Siemens ... a long-term agreement naming BC Technical as the authorized ... MiE and BC Technical announced today that ... establish BC Technical as the service and systems provider ...
(Date:7/10/2014)... CVS Caremark Corporation (NYSE: CVS ) today announced ... of $0.275 (27.5 cents) per share on the corporation,s common ... holders of record on July 21, 2014. About ... helping people on their path to better health as the ... . Through the company,s more than 7,600 CVS/pharmacy stores; ...
(Date:1/15/2014)... , Jan. 15, 2014  Research and Markets ( http://www.researchandmarkets.com/research/6k27gw/dental ... Consumables Market - Global Industry Analysis, Size, Share, Growth, ... their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ... are used on patients in order to treat dental ...
Breaking Medicine Technology:BC Technical Partners With MiE America To Be Authorized Provider Of Systems & Service 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3
... COTTAGE, N.Y., June 30 XTL,Biopharmaceuticals Ltd. (Nasdaq: ... patient randomization into its Phase 2b study of Bicifadine,-- ... the,treatment of diabetic neuropathic pain. 350 patients were randomized ... Company expects to,have the last patient complete the study ...
... new understanding of,the role played by the protein ... novel therapies to rebuild muscle tissue,damaged by disease, ... Institute for Cancer Research and Molecular Medicine at ... The researchers reported their findings, "Cdk9-55: A ...
Cached Medicine Technology:XTL Biopharmaceuticals Announces Completion of Patient Randomization Into the Bicifadine Phase 2b Clinical Trial for the Treatment of Diabetic Neuropathic Pain 2XTL Biopharmaceuticals Announces Completion of Patient Randomization Into the Bicifadine Phase 2b Clinical Trial for the Treatment of Diabetic Neuropathic Pain 3International Team Locates Key Player in Muscle Regeneration 2
(Date:7/11/2014)... Biostimulants are widely applied in turf ... ornamentals. These also help turf and ornamentals in absorption ... Turf, ornamentals, and flowers appear healthy and strong as ... increased from the last few years. The most dominating ... Europe, with around 40% share in 2013, and is ...
(Date:7/11/2014)... Researchers from The Miriam Hospital have found that ... significantly higher rates of smoking than those without ... less likely to attempt quitting than those without ... be sufficient for this population. The study and ... print in the American Journal of Public ...
(Date:7/11/2014)... 2014 The Corn Farming ... 2014 on the heels of fresh biofuel demand. The ... dedicate a larger share of their farmland to cultivating ... regulations required the mixing of 5.0% renewable content in ... the United States created a key export market for ...
(Date:7/11/2014)... FRIDAY, July 11, 2014 (HealthDay News) -- Prostate cancer ... disease, receive less effective treatment and die sooner if ... Researchers analyzed data from more than 41,200 American men ... and 2007. They followed them through 2009. Nearly 1,900 ... the two years before their prostate cancer was discovered. ...
(Date:7/11/2014)... 11, 2014 Riverside Health System became the ... in Virginia in late 2012 and now, in partnership with ... residents throughout the Williamsburg and Newport News region. , Also ... and benefits to independent older adults who wish to remain ... safety net of continuing care services as well as control ...
Breaking Medicine News(10 mins):Health News:Biostimulants Market in Turf and Ornamentals is Expected to Reach $ 3.8 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:Biostimulants Market in Turf and Ornamentals is Expected to Reach $ 3.8 Billion by 2018 - New Report by MicroMarket Monitor 3Health News:Miriam Hospital study examines smoking prevalence 2Health News:Corn Farming in Canada Industry Market Research Report Now Available From IBISWorld 2Health News:Corn Farming in Canada Industry Market Research Report Now Available From IBISWorld 3Health News:Depression May Make It Harder to Beat Prostate Cancer 2Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 2Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 3Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 4
... in Care, The experience of Ontario, Canada ... inequities but not education-related disparities in health care ... data on more than 25,558 residents of Ontario, ... covered by government, researchers find patient income levels ...
... related to heart disease, study shows , MONDAY, Sept. 21 ... at higher risk for having a heart attack, especially those ... both seasonal and the pandemic H1N1 swine flu are circulating ... are urged to get a seasonal flu shot and an ...
... of a specific gene variant shows a strong ... (UC) have demonstrated. In addition, the research indicates ... individuals harboring the gene variant can be further ... Stambrook, PhD, a professor in the department of ...
... , , SACRAMENTO, Calif., ... the Twin Rivers Unified School District will be able to ... created jointly by the California Dental Association Foundation, University of ... California HealthCare Foundation with start-up funding from Verizon. , ...
... 21 HTH Worldwide, a global health and safety ... are now available with sickness, accident and medical evacuation ... that include direct payment to participating doctors and hospitals ... the market today limit medical benefits to $25,000 or ...
... MARINA DEL REY, Calif., Sept. 21 Electronic medical records have ... Dr. Richard Merkin, CEO for Heritage Provider Network. HPN and its ... York have been eliminating waste and cutting costs while providing quality ... on the importance of integrating electronic medical records. , , ...
Cached Medicine News:Health News:September/October 2009 Annals of Family Medicine tip sheet 2Health News:September/October 2009 Annals of Family Medicine tip sheet 3Health News:September/October 2009 Annals of Family Medicine tip sheet 4Health News:September/October 2009 Annals of Family Medicine tip sheet 5Health News:September/October 2009 Annals of Family Medicine tip sheet 6Health News:Flu Can Raise Chances of Heart Attack 2Health News:Flu Can Raise Chances of Heart Attack 3Health News:Cancer predisposition from genetic variation shows strong gender bias 2Health News:New Tele-Health Care Project to Provide Dental Care to Underserved Communities in California 2Health News:New Tele-Health Care Project to Provide Dental Care to Underserved Communities in California 3Health News:New Tele-Health Care Project to Provide Dental Care to Underserved Communities in California 4Health News:HTH Worldwide Introduces Trip Protection Insurance With Major Medical Benefits 2Health News:Heritage Provider Network and Dr. Richard Merkin Highlight Cutting Health Care Costs Using Electronic Medical Records 2
Li Brand™ Surgical Hemostat. ("dissecting clamp") For NSV and other procedures....
... for applications such as vasectomy that ... ,The autoclavable handpiece with six-foot cord ... cautery electrodes, allowing the physician to ... wide variety of procedures., ,The 2201 ...
No Scalpel Vasectomy Hemostat 5 1/2" (14cm), smooth sharp point, curved, gold finger rings...
Li Brand™ Ringed Forceps. ("fixation clamp") For NSV and other procedures. Ring diameter approximately 3.5 mm. Manufactured exclusively for AMI to exacting specifications by a German company....
Medicine Products: